Global Enterobacteriaceae Infection Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Enterobacteriaceae Infection Drug Market Overview

• 1.1 Product Overview and Scope of Enterobacteriaceae Infection Drug
• 1.2 Classification of Enterobacteriaceae Infection Drug by Types
  • 1.2.1 Global Enterobacteriaceae Infection Drug Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Types in 2018
  • 1.2.3 Beta-lactams Drugs
  • 1.2.4 Carbapenems Drugs
  • 1.2.5 Fluoroquinolones Drugs
  • 1.2.6 Others
• 1.3 Global Enterobacteriaceae Infection Drug Market by Application
  • 1.3.1 Global Enterobacteriaceae Infection Drug Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Online Pharmacies
• 1.4 Global Enterobacteriaceae Infection Drug Market by Regions
  • 1.4.1 Global Enterobacteriaceae Infection Drug Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Enterobacteriaceae Infection Drug Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Enterobacteriaceae Infection Drug Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Enterobacteriaceae Infection Drug Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Enterobacteriaceae Infection Drug Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Enterobacteriaceae Infection Drug Status and Prospect (2014-2024)
• 1.5 Global Market Size of Enterobacteriaceae Infection Drug (2014-2024)

2 Company Profiles

• 2.1 Genentech
  • 2.1.1 Business Overview
  • 2.1.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Genentech Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Cantab Biopharmaceuticals
  • 2.2.1 Business Overview
  • 2.2.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Pfizer
  • 2.3.1 Business Overview
  • 2.3.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Pfizer Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Nanotherapeutics
  • 2.4.1 Business Overview
  • 2.4.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Nanotherapeutics Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Phico Therapeutics
  • 2.5.1 Business Overview
  • 2.5.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Phico Therapeutics Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Novartis
  • 2.6.1 Business Overview
  • 2.6.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Novartis Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Sequoia Sciences
  • 2.7.1 Business Overview
  • 2.7.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Sequoia Sciences Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Nymox Pharmaceutical
  • 2.8.1 Business Overview
  • 2.8.2 Enterobacteriaceae Infection Drug Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2017-2018)

3 Global Enterobacteriaceae Infection Drug Market Competition, by Players

• 3.1 Global Enterobacteriaceae Infection Drug Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Enterobacteriaceae Infection Drug Players Market Share
  • 3.2.2 Top 10 Enterobacteriaceae Infection Drug Players Market Share
• 3.3 Market Competition Trend

4 Global Enterobacteriaceae Infection Drug Market Size by Regions

• 4.1 Global Enterobacteriaceae Infection Drug Revenue and Market Share by Regions
• 4.2 North America Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 4.3 Europe Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 4.5 South America Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)

5 North America Enterobacteriaceae Infection Drug Revenue by Countries

• 5.1 North America Enterobacteriaceae Infection Drug Revenue by Countries (2014-2019)
• 5.2 USA Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 5.3 Canada Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)

6 Europe Enterobacteriaceae Infection Drug Revenue by Countries

• 6.1 Europe Enterobacteriaceae Infection Drug Revenue by Countries (2014-2019)
• 6.2 Germany Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 6.3 UK Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 6.4 France Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 6.5 Russia Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 6.6 Italy Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Enterobacteriaceae Infection Drug Revenue by Countries

• 7.1 Asia-Pacific Enterobacteriaceae Infection Drug Revenue by Countries (2014-2019)
• 7.2 China Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 7.3 Japan Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 7.4 Korea Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 7.5 India Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)

8 South America Enterobacteriaceae Infection Drug Revenue by Countries

• 8.1 South America Enterobacteriaceae Infection Drug Revenue by Countries (2014-2019)
• 8.2 Brazil Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Enterobacteriaceae Infection Drug by Countries

• 9.1 Middle East and Africa Enterobacteriaceae Infection Drug Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 9.3 UAE Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Enterobacteriaceae Infection Drug Revenue and Growth Rate (2014-2019)

10 Global Enterobacteriaceae Infection Drug Market Segment by Type

• 10.1 Global Enterobacteriaceae Infection Drug Revenue and Market Share by Type (2014-2019)
• 10.2 Global Enterobacteriaceae Infection Drug Market Forecast by Type (2019-2024)
• 10.3 Beta-lactams Drugs Revenue Growth Rate (2014-2024)
• 10.4 Carbapenems Drugs Revenue Growth Rate (2014-2024)
• 10.5 Fluoroquinolones Drugs Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Enterobacteriaceae Infection Drug Market Segment by Application

• 11.1 Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2014-2019)
• 11.2 Enterobacteriaceae Infection Drug Market Forecast by Application (2019-2024)
• 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
• 11.4 Retail Pharmacies Revenue Growth (2014-2019)
• 11.5 Online Pharmacies Revenue Growth (2014-2019)

12 Global Enterobacteriaceae Infection Drug Market Size Forecast (2019-2024)

• 12.1 Global Enterobacteriaceae Infection Drug Market Size Forecast (2019-2024)
• 12.2 Global Enterobacteriaceae Infection Drug Market Forecast by Regions (2019-2024)
• 12.3 North America Enterobacteriaceae Infection Drug Revenue Market Forecast (2019-2024)
• 12.4 Europe Enterobacteriaceae Infection Drug Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Enterobacteriaceae Infection Drug Revenue Market Forecast (2019-2024)
• 12.6 South America Enterobacteriaceae Infection Drug Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Enterobacteriaceae Infection Drug Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology